Financial disclosure by clinical investigators (21 CFR 54.1-54.6). Country/Territory United States of America Document type Regulation Date 2016 (1999) Source FAO, FAOLEX Original source Code of Federal Regulations - Title 21 - Food and Drugs. Subject Food & nutrition Keyword Food quality control/food safety Legal proceedings/administrative proceedings Inspection Authorization/permit Geographical area Americas, Arctic, East Pacific, North America, North Atlantic Abstract Part 54 of Title 21 of the Federal Code of Regulations defines the financial disclosure by clinical investigators in terms of administrative procedures regarding the clinical studies aimed to determine whether the applications are approvable under the statutory requirement (also for biological products and including the potential increase in the value of the interest if a specific product is approved). Full text English Website www.gpo.gov References - Legislation Implements Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301-399d). Legislation | United States of America | 1938 (2021) Keyword: Basic legislation, Food quality control/food safety, Hygiene/sanitary procedures, Packaging/labelling, Food additives, Residues, MRL-maximum residue limit, Standards, Registration, Inspection, Traceability/product tracing, Treated food, HACCP, Fish products, Fraud, Enforcement/compliance, Offences/penalties, Pesticides, Animal health, Animal feed/feedstuffs, Drugs Source: FAO, FAOLEX